Evidence map›Paper›PMID 41450763›Full record

ArticleResults in chemistry2023

Convenient synthesis and in vitro activity of oxalyl bis(benzenesulfonylhydrazides) and related compounds.

Jozef Stec, Shang Xie, Lena Alshukri, Gina J Kang, Paula K Hudson, Stevan Pecic

Abstract read
In one paragraph

Article in Results in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jozef StecDepartment of Pharmaceutical Sciences, College of Pharmacy, Marshall B. Ketchum University, 2575 Yorba Linda Blvd., Fullerton, California 92831, United States.
Shang XieDepartment of Pharmaceutical Sciences, College of Pharmacy, Marshall B. Ketchum University, 2575 Yorba Linda Blvd., Fullerton, California 92831, United States.
Lena AlshukriDepartment of Pharmaceutical Sciences, College of Pharmacy, Marshall B. Ketchum University, 2575 Yorba Linda Blvd., Fullerton, California 92831, United States.
Gina J KangDepartment of Chemistry and Biochemistry, California State University Fullerton, 800 N. State College Blvd., Fullerton, California 92834, United States.
Paula K HudsonDepartment of Chemistry and Biochemistry, California State University Fullerton, 800 N. State College Blvd., Fullerton, California 92834, United States.
Stevan PecicDepartment of Chemistry and Biochemistry, California State University Fullerton, 800 N. State College Blvd., Fullerton, California 92834, United States.

Funding

Development of dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors as a Promising Therapeutic Strategy for the Treatment of Acute and Chronic PainSC2GM135020 · NIGMS · CALIFORNIA STATE UNIVERSITY FULLERTON · PI PECIC, STEVAN · 2020 to 2022
$426k
NIGMS NIH HHS SC2 GM135020
6 · The paper itself

Abstract

Symmetrical oxalyl bis(benzenesulfonylhydrazides) [ObBSH] were conveniently prepared by reacting various sulfonyl hydrazides with oxalyl chloride in refluxing tetrahydrofuran (or toluene). The crude products were obtained practically as virtually pure compounds in high yields. While synthetic access to oxalyl bis(benzenesulfonylhydrazides) has been described in the literature, this report delineates a facile protocol for preparing such type of compounds under relatively mild conditions from inexpensive, commercially available, and chemically stable reagents. Non-symmetrical oxalyl ObBSH were also obtained via modified one-pot, two-step synthetic protocol. However, those products required purification due to contaminations arising from the concurrent formation of the symmetrical counterparts. These newly synthesized molecules were screened in an acetylcholinesterase in vitro enzymatic assay. Several compounds showed inhibitory potency in low micromolar range, which aligns with results reported previously for similar compounds. Overall, the synthetic protocols presented herein revisit the preparation of oxalyl bis(benzenesulfonylhydrazides), which have been previously characterized as blowing agents possessing potential for commercial applications and might be also further explored in search of bioactive properties.

Indexed as

blowing agentsone-pot synthesisoxalyl bis(benzenesulfonylhydrazides) [ObBSH]symmetrical compounds

Identifiers

PMID41450763
PMCPMC12735230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.